In 2023, David Chang, M.D., Ph.D. earned $994.60K in total compensation at Allogene Therapeutics, including $724.00K salary and $270.60K bonus. Most recently sold 93,336 shares in Mar 2025. Currently holds stock worth $8.77M. Led Allogene Therapeutics as CEO for 4 years.
Compensation History
Annual executive compensation data for David Chang, M.D., Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$994.60K
Salary
$724.00K
Bonus
$270.60K
Other
$0.00
Salary
$724.00KBoard Justification
The compensation philosophy emphasizes a pay-for-performance structure, aligning executive compensation with company performance and retention strategies.
Bonus
$270.60KBoard Justification
The annual performance-based cash incentive for 2023 was based on the achievement of corporate goals, which were scored at 57.5%.
Other Compensation
$0.00Board Justification
No additional compensation was reported outside of salary, bonus, and stock options.
Restricted Stock
Board Justification
No stock was reported as vested in 2023; the focus is on the total compensation excluding stock grants.
Performance Metrics
The performance metrics for 2023 included corporate goals related to clinical and operational objectives.
David Chang, M.D., Ph.D.
Founder and Ex-CEO of Allogene Therapeutics
Education
M.D. and Ph.D.
Field of Expertise
Healthcare & Life Sciences - Biomedical
Sector of Economy
Healthcare
Born
January 1, 1978 - 47 years ago
CEO of Allogene Therapeutics for
4 years 10 months (Dec 2018 - Oct 2023)
Previous Experience
Chief Executive Officer of Allogene Therapeutics, Inc.
Other Allogene Therapeutics CEOs
Holdings
Track David Chang, M.D., Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$1.62M
$1.62M
203,835 ALLO shares
What if they kept their stock?
If David Chang, M.D., Ph.D. didn't sell their stock, today they would have:
Extra ALLO203,835 shares worth $291.48K.
This is -81.97% and $1.33M less than what they got when they sold the stock.
Insider Trading
David Chang, M.D., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$182.94K
ALLO at $1.96/share
Mar 14, 2025
Sale
$77.29K
ALLO at $1.68/share
Feb 3, 2025
Sale
552,174 shares
ALLO
Jan 24, 2025
Received
$1.00M
ALLO at $2.90/share
May 16, 2024
Received
317,800 shares
ALLO
Jan 25, 2024
Received
1,924,464 shares
ALLO
Mar 22, 2023
Received
$180.88K
ALLO at $7.65/share
Mar 15, 2022
Sale
80,452 shares
ALLO
Mar 26, 2021
Received
$791.27K
ALLO at $38.57/share
Mar 15, 2021
Sale
411,556 shares
ALLO
Mar 26, 2021
Charity
Rivals
Compare David Chang, M.D., Ph.D. with competitor CEOs and industry peers.